Search
for
Sort by
Research 61–90 of 1000+
- Dermatological Manifestations of COVID-19: A Brief Review
- Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia
- Mucocutaneous reactions to chemotherapy
- Index of Suspicion
- PROFILE OF SKIN CHANGES AND ITS ASSOCIATION WITH BIOCHEMICAL PARAMETERS IN HAEMODIALYSIS PATIENTS
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- Cicatricial alopecia
- Erosive pustular dermatosis of the scalp and multiple sclerosis: just a coincidence?
- Chancres in Syphilis-Reply
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- A Clinical Study on Cutaneous Manifestations of Obesity
- 6. Phototherapy, Photomedicine, and Pigmentary Disorders
- 12. Cancer
- Dermatoses of pregnancy
- Dermatologic Reactions to Targeted Therapy
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Primary cicatricial alopecias
- British Hair and Nail Society
- Vaccines, Infections, and Alopecia Areata
- Secondary cicatricial and other permanent alopecias
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Involvement of scalp and nails in lupus erythematosus
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Unconventional medicine in dermatology outpatients in Turkey